These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 17541126

  • 1. Interatrial septal defect closure for prevention of cerebrovascular accidents: impact on recurrence and frequency of migraine headaches.
    Shammas NW, Dippel EJ, Harb G, Egts S, Jerin M, Stoakes P, Byrd J, Shammas GA, Sharis P.
    J Invasive Cardiol; 2007 Jun; 19(6):257-60. PubMed ID: 17541126
    [Abstract] [Full Text] [Related]

  • 2. Interatrial septal defect closure for cerebrovascular accidents: exploring the role of various anticoagulants.
    Shammas NW, Dippel EJ, Harb G, Egts S, Jerin M, Stoakes P, Byrd J, Shammas GA, Sharis P.
    J Invasive Cardiol; 2007 Jul; 19(7):309-12. PubMed ID: 17620676
    [Abstract] [Full Text] [Related]

  • 3. Migraine headache relief after transcatheter closure of patent foramen ovale.
    Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA.
    J Am Coll Cardiol; 2005 Feb 15; 45(4):493-5. PubMed ID: 15708692
    [Abstract] [Full Text] [Related]

  • 4. Association of interatrial shunts and migraine headaches: impact of transcatheter closure.
    Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R.
    J Am Coll Cardiol; 2005 Feb 15; 45(4):489-92. PubMed ID: 15708691
    [Abstract] [Full Text] [Related]

  • 5. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting.
    Giardini A, Donti A, Formigari R, Salomone L, Prandstraller D, Bonvicini M, Palareti G, Guidetti D, Gaddi O, Picchio FM.
    Am Heart J; 2006 Apr 15; 151(4):922.e1-5. PubMed ID: 16569564
    [Abstract] [Full Text] [Related]

  • 6. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.
    Harms V, Reisman M, Fuller CJ, Spencer MP, Olsen JV, Krabill KA, Gray WA, Jesurum JT.
    Am J Cardiol; 2007 May 01; 99(9):1312-5. PubMed ID: 17478164
    [Abstract] [Full Text] [Related]

  • 7. Outcome after percutaneous closure of a patent foramen ovale using the Intrasept device: a multi-centre study.
    Luermans JG, Post MC, Schräder R, Sluysmans T, Vydt T, Vermeersch P, Chessa M, Onorato E, Goy JJ, Budts WI.
    Catheter Cardiovasc Interv; 2008 May 01; 71(6):822-8. PubMed ID: 18324695
    [Abstract] [Full Text] [Related]

  • 8. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J, Mineau S, Marrero A, Houde C, Mackey A, Côté JM, Chetaille P, Delisle G, Bertrand OF, Rivest D.
    Am J Cardiol; 2008 Mar 01; 101(5):688-92. PubMed ID: 18308022
    [Abstract] [Full Text] [Related]

  • 9. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G, Cardaioli P, Braggion G, Giordan M, Fabio D, Aggio S, Roncon L, Chinaglia M.
    Catheter Cardiovasc Interv; 2007 Sep 01; 70(3):429-33. PubMed ID: 17722021
    [Abstract] [Full Text] [Related]

  • 10. The influence of percutaneous atrial septal defect closure on the occurrence of migraine.
    Mortelmans K, Post M, Thijs V, Herroelen L, Budts W.
    Eur Heart J; 2005 Aug 01; 26(15):1533-7. PubMed ID: 15746154
    [Abstract] [Full Text] [Related]

  • 11. Exclusion of patients with arteriosclerosis reduces long-term recurrence rate of presumed arterial embolism after PFO closure.
    Dubiel M, Bruch L, Liebner M, Schmehl I, Winkelmann A, Rux S, Sonntag S, Wulff H, Grad MO, Kleber FX.
    J Interv Cardiol; 2007 Aug 01; 20(4):275-81. PubMed ID: 17680857
    [Abstract] [Full Text] [Related]

  • 12. Transcatheter closure of patent foramen ovale in older adults.
    Kiblawi FM, Sommer RJ, Levchuck SG.
    Catheter Cardiovasc Interv; 2006 Jul 01; 68(1):136-42; discussion 143-4. PubMed ID: 16755591
    [Abstract] [Full Text] [Related]

  • 13. Right-to-left shunt, atrial septal aneurysm and thrombophilia in patients with cryptogenic stroke or TIA vs. those with venous thrombo-embolism.
    Palmieri V, Tufano A, Carmen Bonito M, Martino S, Sabatella M, Di Minno G, Celentano A.
    Int J Cardiol; 2008 Oct 30; 130(1):99-102. PubMed ID: 17643530
    [Abstract] [Full Text] [Related]

  • 14. PFO closure for prevention of recurrent stroke in patients after cryptogenic stroke: the imperative of completing randomized controlled trials.
    Kaplan AV, Lukovits TG, Robb JF.
    Catheter Cardiovasc Interv; 2007 Jan 30; 69(1):6-8. PubMed ID: 17173274
    [No Abstract] [Full Text] [Related]

  • 15. Migraine headache relief after percutaneous transcatheter closure of interatrial communications.
    Dubiel M, Bruch L, Schmehl I, Liebner M, Winkelmann A, Stretz A, Grad MO, Kleber FX.
    J Interv Cardiol; 2008 Feb 30; 21(1):32-7. PubMed ID: 18093099
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M, Gaspardone A, Fragasso G, Ajello S, Gioffrè G, Iamele M, Iani C, Margonato A.
    Am J Cardiol; 2009 Aug 01; 104(3):434-9. PubMed ID: 19616680
    [Abstract] [Full Text] [Related]

  • 17. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
    Kutty S, Brown K, Asnes JD, Rhodes JF, Latson LA.
    Am J Cardiol; 2008 May 15; 101(10):1487-92. PubMed ID: 18471463
    [Abstract] [Full Text] [Related]

  • 18. Patent foramen ovale and migraine.
    Post MC, Luermans JG, Plokker HW, Budts W.
    Catheter Cardiovasc Interv; 2007 Jan 15; 69(1):9-14. PubMed ID: 17143907
    [Abstract] [Full Text] [Related]

  • 19. Relation of atrial shunts to migraine in patients with ischemic stroke and peripheral emboli.
    Wilmshurst P, Nightingale S, Pearson M, Morrison L, Walsh K.
    Am J Cardiol; 2006 Sep 15; 98(6):831-3. PubMed ID: 16950197
    [Abstract] [Full Text] [Related]

  • 20. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 15; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.